Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials

0
300
Potential new treatment for COVID-19 uncovered by BenevolentAI enters trials

BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as a potential treatment for COVID-19, after it applied its AI platform and team to the problem. The revelation, whi…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here